查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710114

2025年全球癌症活体组织切片市场报告

Cancer Biopsy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年癌症活体组织切片市场规模将快速成长。到 2029 年，这一数字将成长至 472 亿美元，年复合成长率（CAGR）为 13.4%。预测期内的增长是由于患者数量的增加、老年人口的增加、疑似患有乳癌的患者数量的增加、癌症病例数量的增加、诊断和切片检查测试数量的增加以及患者数量的增加。预测期内的主要趋势包括技术进步、人工智慧和机器学习、多体学整合、产品创新和照护现场切片检查。

预计癌症发病率的上升将推动癌症活体组织切片市场的成长。癌症的特征是异常细胞的生长和扩散，由于生活方式改变、都市化、环境污染、烟草和酒精消费以及医疗保健机会和意识的差异等因素，癌症变得越来越普遍。切片检查透过从可疑区域取出并分析组织或细胞，对于诊断和评估癌症的类型、阶段和进展至关重要。例如，美国国家生物技术资讯中心报告称，2023年1月，美国新增癌症病例1,958,310例，癌症相关死亡病例609,820例。此外，根据美国国家医学图书馆2021年5月发布的报告，预计到2040年全球癌症患者数将达到2,840万人，比2020年增加47%，死亡率也将随之上升。盛行率的不断上升是推动切片检查需求的关键因素。

癌症活体组织切片市场的主要企业正在推进液态切片技术，以实现癌症的非侵入性早期检测和监测，从而改善患者的治疗效果并支持更个人化的治疗方法。液态切片是一种先进的诊断方法，可以分析血液样本中的遗传物质，包括循环肿瘤 DNA (ctDNA)、RNA、外泌体和其他生物标记。 Labcorp 是美国癌症活体组织切片解决方案的领导者，于 2023 年 5 月推出了 Labcorp Plasma Focus，这是一种基于血浆的液态切片，旨在检测癌症相关的生物标记。等离子聚焦测试分析血液中癌细胞的循环游离 DNA（cfDNA），以创建患者肿瘤的基因组图谱，并识别与一系列癌症相关的 33 个基因的突变，包括非小细胞肺癌、结直肠癌、乳癌、食道癌和黑色素瘤。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球癌症活体组织切片PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球癌症活体组织切片市场：成长率分析
  • 全球癌症活体组织切片市场表现：规模与成长，2019-2024
  • 全球癌症活体组织切片市场预测：2024-2029 年及 2034 年规模与成长
  • 全球癌症活体组织切片总目标市场（TAM）

第六章市场区隔

  • 全球癌症活体组织切片市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 组织切片检查
  • 液态生物检体
  • 其他类型
  • 全球癌症活体组织切片市场：按应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 乳癌
  • 大肠直肠癌
  • 子宫颈癌
  • 肺癌
  • 摄护腺癌
  • 皮肤癌
  • 血癌
  • 肾癌
  • 其他用途
  • 全球癌症活体组织切片市场：按最终用户、业绩和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断实验室
  • 其他最终用户
  • 全球癌症活体组织切片市场依组织切片检查类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 芯针切片
  • 细针抽吸（FNA）切片检查
  • 切口切片检查
  • 切除切片检查
  • 全球癌症活体组织切片市场，依液态生物检体类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 循环性肿瘤细胞（CTC）分析
  • 循环肿瘤DNA（ctDNA）检测
  • 血浆生物标记检测
  • 全球癌症活体组织切片市场，按类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 骨切片检查
  • 内视镜切片检查
  • 刷切片检查
  • 皮肤切片检查

第七章 区域和国家分析

  • 全球癌症活体组织切片市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球癌症活体组织切片市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 癌症活体组织切片市场：竞争格局
  • 癌症活体组织切片市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Veracyte Inc.
  • GRAIL Inc.
  • Freenome Holdings Inc.
  • Biodesix Inc.
  • Chronix Biomedical Inc.
  • Biocept Inc.
  • Personal Genome Diagnostics Inc.
  • Agena Bioscience Inc.
  • Oncimmune Holdings plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年癌症活体组织切片市场：提供新机会的国家
  • 2029 年癌症活体组织切片市场：细分领域带来新机会
  • 2029年癌症活体组织切片市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31693

A cancer biopsy is a medical procedure in which a small sample of tissue or cells is extracted from a suspicious area of the body to determine the presence of cancer or other conditions. This procedure is essential for diagnosing cancer, as imaging tests such as CT scans or MRIs cannot definitively differentiate between cancerous and non-cancerous cells.

The primary types of cancer biopsies include tissue biopsies, liquid biopsies, and others. Tissue biopsies involve extracting a small tissue sample from the body for microscopic examination. These procedures are used to diagnose various types of cancer, including breast, colorectal, cervical, lung, prostate, skin, blood, kidney, and other cancers. They are employed by different end users, such as hospitals, diagnostic laboratories, and other healthcare facilities.

The cancer biopsy market research report is one of a series of new reports from The Business Research Company that provides cancer biopsy market statistics, including cancer biopsy industry global market size, regional shares, competitors with a cancer biopsy market share, detailed cancer biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer biopsy industry. This cancer biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer biopsy market size has grown rapidly in recent years. It will grow from $25.08 $ billion in 2024 to $28.52 $ billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing awareness of breast cancer liquid biopsy procedures, rising awareness of inherited oncology disorders and genetic testing, increasing adoption of liquid biopsies, increasing demand of for minimally invasive biopsy treatments, increasing demand for tissue biopsies.

The cancer biopsy market size is expected to see rapid growth in the next few years. It will grow to $47.2 $ billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to an increase in the number of patients, the growing elderly population, the growing number of patients suspected of having breast cancer, the rise in cancer cases, an increase in the diagnosis and biopsies testing, increase in the number of patients. Major trends in the forecast period include technological advancements, artificial intelligence and machine learning, integration of multi-omics, product innovations, and point-of-care biopsy devices.

The increasing incidence of cancer is expected to drive growth in the cancer biopsy market. Cancer, characterized by abnormal cell growth and spread, is becoming more prevalent due to factors such as lifestyle changes, urbanization, environmental pollution, tobacco and alcohol consumption, and disparities in healthcare access and awareness. Cancer biopsies are crucial for diagnosing and assessing cancer type, stage, and progression by extracting and analyzing tissue or cells from suspicious areas. For instance, the National Center for Biotechnology Information reported in January 2023 that the United States had 1,958,310 new cancer cases and 609,820 cancer-related deaths. Additionally, a May 2021 report from the National Library of Medicine forecasted a global cancer burden of 28.4 million cases by 2040, representing a 47% increase from 2020, along with a corresponding rise in mortality rates. This growing prevalence is a significant factor driving the demand for cancer biopsies.

Key players in the cancer biopsy market are advancing liquid biopsy technologies to enable non-invasive, early detection and monitoring of cancer, thereby improving patient outcomes and supporting more personalized treatment approaches. Liquid biopsy is an advanced diagnostic method that analyzes genetic material in blood samples, including circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. In May 2023, Labcorp, a US-based leader in cancer biopsy solutions, launched Labcorp Plasma Focus, a plasma-based liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) from tumor cells in the bloodstream to generate a genomic profile of the patient's tumor, identifying mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

In June 2023, Quest Diagnostics, a US-based provider of diagnostic information services, acquired Haystack Oncology for up to $450 million. This acquisition aims to enhance Quest Diagnostics' expertise in cancer diagnostics, particularly in the detection of minimal residual disease (MRD). Haystack Oncology is a US-based company that specializes in liquid biopsy technology for cancer detection.

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

North America was the largest region in the cancer biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer biopsy market consists of sales of biopsy needles, biopsy guns, and biopsy punches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tissue Biopsies; Liquid Biopsies; Other Types
  • 2) By Application: Breast Cancer; Colorectal Cancer; Cervical Cancers; Lung Cancers; Prostate Cancers; Skin Cancers; Blood Cancers; Kidney Cancers; Other Applications
  • 3) By End User: Hospitals; Diagnostic Laboratories; Other End Users
  • Subsegments:
  • 1) By Tissue Biopsies: Core Needle Biopsies; Fine Needle Aspiration (FNA) Biopsies; Incisional Biopsies; Excisional Biopsies
  • 2) By Liquid Biopsies: Circulating Tumor Cell (CTC) Analysis; Circulating Tumor DNA (ctDNA) Testing; Plasma Biomarker Testing
  • 3) By Other Types: Bone Biopsies; Endoscopic Biopsies; Brush Biopsies; Skin Biopsies
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Roche Diagnostics GmbH; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Biopsy Market Characteristics

3. Cancer Biopsy Market Trends And Strategies

4. Cancer Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Biopsy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cancer Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cancer Biopsy Market Growth Rate Analysis
  • 5.4. Global Cancer Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cancer Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cancer Biopsy Total Addressable Market (TAM)

6. Cancer Biopsy Market Segmentation

  • 6.1. Global Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Biopsies
  • Liquid Biopsies
  • Other Types
  • 6.2. Global Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Other Applications
  • 6.3. Global Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Other End Users
  • 6.4. Global Cancer Biopsy Market, Sub-Segmentation Of Tissue Biopsies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Core Needle Biopsies
  • Fine Needle Aspiration (FNA) Biopsies
  • Incisional Biopsies
  • Excisional Biopsies
  • 6.5. Global Cancer Biopsy Market, Sub-Segmentation Of Liquid Biopsies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Circulating Tumor Cell (CTC) Analysis
  • Circulating Tumor DNA (ctDNA) Testing
  • Plasma Biomarker Testing
  • 6.6. Global Cancer Biopsy Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone Biopsies
  • Endoscopic Biopsies
  • Brush Biopsies
  • Skin Biopsies

7. Cancer Biopsy Market Regional And Country Analysis

  • 7.1. Global Cancer Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cancer Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Biopsy Market

  • 8.1. Asia-Pacific Cancer Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Biopsy Market

  • 9.1. China Cancer Biopsy Market Overview
  • 9.2. China Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Biopsy Market

  • 10.1. India Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Biopsy Market

  • 11.1. Japan Cancer Biopsy Market Overview
  • 11.2. Japan Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Biopsy Market

  • 12.1. Australia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Biopsy Market

  • 13.1. Indonesia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Biopsy Market

  • 14.1. South Korea Cancer Biopsy Market Overview
  • 14.2. South Korea Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Biopsy Market

  • 15.1. Western Europe Cancer Biopsy Market Overview
  • 15.2. Western Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Biopsy Market

  • 16.1. UK Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Biopsy Market

  • 17.1. Germany Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Biopsy Market

  • 18.1. France Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Biopsy Market

  • 19.1. Italy Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Biopsy Market

  • 20.1. Spain Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Biopsy Market

  • 21.1. Eastern Europe Cancer Biopsy Market Overview
  • 21.2. Eastern Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Biopsy Market

  • 22.1. Russia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Biopsy Market

  • 23.1. North America Cancer Biopsy Market Overview
  • 23.2. North America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Biopsy Market

  • 24.1. USA Cancer Biopsy Market Overview
  • 24.2. USA Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Biopsy Market

  • 25.1. Canada Cancer Biopsy Market Overview
  • 25.2. Canada Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Biopsy Market

  • 26.1. South America Cancer Biopsy Market Overview
  • 26.2. South America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Biopsy Market

  • 27.1. Brazil Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Biopsy Market

  • 28.1. Middle East Cancer Biopsy Market Overview
  • 28.2. Middle East Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Biopsy Market

  • 29.1. Africa Cancer Biopsy Market Overview
  • 29.2. Africa Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Biopsy Market Competitive Landscape
  • 30.2. Cancer Biopsy Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Biopsy Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. Exact Sciences Corporation
  • 31.5. Myriad Genetics Inc.
  • 31.6. Guardant Health Inc.
  • 31.7. Veracyte Inc.
  • 31.8. GRAIL Inc.
  • 31.9. Freenome Holdings Inc.
  • 31.10. Biodesix Inc.
  • 31.11. Chronix Biomedical Inc.
  • 31.12. Biocept Inc.
  • 31.13. Personal Genome Diagnostics Inc.
  • 31.14. Agena Bioscience Inc.
  • 31.15. Oncimmune Holdings plc

32. Global Cancer Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Biopsy Market

34. Recent Developments In The Cancer Biopsy Market

35. Cancer Biopsy Market High Potential Countries, Segments and Strategies

  • 35.1 Cancer Biopsy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cancer Biopsy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cancer Biopsy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer